Navigation Links
Tetrabenazine in Medical News

FDA Advisory Committee Votes Unanimously to Recommend Approval of Tetrabenazine for Chorea Associated With Huntington Disease

WASHINGTON, Dec. 6 /PRNewswire/ -- An advisory committee to the U.S. Food and Drug Administration (FDA) today voted unanimously to recommend the approval of tetrabenazine, which would be the first drug approved in the United States to treat chorea associated with Huntington disease (HD). "Th...

FDA approves first drug for Huntington's disease

... be diagnosed with the disease. FDA has classified tetrabenazine as an "orphan drug," since it's targeted to a dise..." said Marshall. "On one hand, the FDA approval of tetrabenazine represents only a small step forward. This medica...al represents a giant symbolic breakthrough, since tetrabenazine is the first drug ever approved in the United Stat...
Tetrabenazine in Medical Technology

Cambridge Laboratories Announces Approval of Tetrabenazine in Spain

DUBLIN and NEWCASTLE, England, December 8 /PRNewswire/ -- - Marketing Partner UCB Expects to Receive Completed Price and Reimbursement Approval for Tetrabenazine in H1 2009 - Exclusive Distribution Rights Granted in Finland (MediFront) and Taiwan (Giddi Pharma); Distribution Contra...

Clinical Trial Results Suggest Long-Term Treatment Benefit of Tetrabenazine for Chorea Associated with Huntington's Disease

...y 3, 2007 - New data show the investigational drug tetrabenazine maintained reduction of chorea associated with Hun...atment in a 13-week trial. These data suggest that tetrabenazine can be used successfully to sustain reduced chorea...we were able to maintain reduced chorea burden." tetrabenazine is designed to reversibly stop the release of dopa...
Tetrabenazine in Biological News

Study finds drug may cut down involuntary movements

... The medication tetrabenazine cut down involuntary movement in patients with Hun...any different side effects. This study shows that tetrabenazine can decrease chorea, and the drug is well-tolerated by most research subjects," said Shannon. tetrabenazine was originally developed in the 1950s to treat psy...
Tetrabenazine in Biological Technology

Marinus Pharmaceuticals Adds Two Life Sciences Veterans to its Board of Directors

...ntures, a leading venture capital firm. Previously, he was CEO of Prestwick Pharmaceuticals, a CNS company that he directed to obtain FDA approval for tetrabenazine (TBZ), the first drug ever licensed in the United States to treat Huntington's Disease patients. Prior to that, Mr. Horner was CEO of Vicuron Pharmace...
Other Tags
(Date:7/25/2014)... Newyorktermlifeinsurance.org has released a new ... and traditional policies. , The newly released blog ... no medical exam life insurance plans and traditional policies. ... insurance plans to provide a simple guide for purchasing ... can now be purchased online. Although traditional plans do ...
(Date:7/25/2014)... Parkulture is proud to announce that ... Jared “JJ” Woods, will be competing on NBC’s highest ... The show will premiere on local affiliates this coming ... the new Esquire Network on Tuesday, July 29th at ... balancing careers as a professional stuntman for film and ...
(Date:7/25/2014)... The new report “Carbohydrase Market by Applications (Food ... Type (Amylases, Cellulases, and Others), Source (Microorganisms, Animals, ... Forecasts to 2019", by MarketsandMarkets, identifies the driving ... with analysis of trends, opportunities, winning imperatives, and ... forecasted on the basis of major regions such ...
(Date:7/25/2014)... July 25, 2014 CarePoint Health is ... Edward Boylan, has joined our network, CarePoint Health Medical ... Hundreds of highly skilled and experienced physicians comprise CarePoint ... and practices in Hudson County, representing a wide range ... to provide the highest quality care to patients and ...
(Date:7/25/2014)... today’s technological era, every organization is dependable on the ... organization in various ways. But there is high risk ... confidential information and processes of the organization. , ... protect the enterprise from various types of threats and ... the comp may. The equipment's of the EGRC market ...
Breaking Medicine News(10 mins):Health News:No Medical Exam Life Insurance and Traditional Plans - Newyorktermlifeinsurance.org Provides Quotes for All Types of Life Insurance 2Health News:Jared “JJ” Woods Prepares for American Ninja Warrior City Finals 2Health News:Jared “JJ” Woods Prepares for American Ninja Warrior City Finals 3Health News:Carbohydrase Market worth $3,717.7 Million by 2019 - Report by MarketsandMarkets 2Health News:Carbohydrase Market worth $3,717.7 Million by 2019 - Report by MarketsandMarkets 3Health News:Carbohydrase Market worth $3,717.7 Million by 2019 - Report by MarketsandMarkets 4Health News:Dr. Boylan Joins CarePoint Health Medical Group 2Health News:North America Enterprise Governance, Risk, and Compliance Market is Expected to Reach $3,972.6 Million in 2018 - New Report by MicroMarket Monitor 2Health News:North America Enterprise Governance, Risk, and Compliance Market is Expected to Reach $3,972.6 Million in 2018 - New Report by MicroMarket Monitor 3Health News:North America Enterprise Governance, Risk, and Compliance Market is Expected to Reach $3,972.6 Million in 2018 - New Report by MicroMarket Monitor 4Health News:North America Enterprise Governance, Risk, and Compliance Market is Expected to Reach $3,972.6 Million in 2018 - New Report by MicroMarket Monitor 5Health News:North America Enterprise Governance, Risk, and Compliance Market is Expected to Reach $3,972.6 Million in 2018 - New Report by MicroMarket Monitor 6
(Date:7/24/2014)... YORK, NY (July 24, 2014) Scientists at ... Institute are one step closer to creating a ... a patient,s own cells. , For the ... (iPS) cells lines from skin samples of patients ... developed an accelerated protocol to induce these stem ...
(Date:7/24/2014)... NY - July 24, 2014 -- Keryx Biopharmaceuticals, Inc. ... the long-term, randomized, active control Phase 3 study of ... phosphate binder, for the treatment of hyperphosphatemia in patients ... study (PhosphatE binding and iRon delivery with FErric CiTrate ... Journal of the American Society of Nephrology ( ...
(Date:7/24/2014)... Scientists at The New York Stem Cell Foundation ... creating a viable cell replacement therapy for multiple ... For the first time, NYSCF scientists generated induced ... of patients with primary progressive multiple sclerosis and ... these stem cells into becoming oligodendrocytes, the myelin-forming ...
Breaking Biology News(10 mins):NYSCF scientists one step closer to cell therapy for multiple sclerosis patients 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4NYSCF scientists 1 step closer to cell therapy for multiple sclerosis patients 2
Other Contents